Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Navitor Pharmaceuticals Inc.
Headquarters: Cambridge, MA, United States of America
Website: http://www.navitorpharma.com...
Year Founded: 2010
Status: Private
BioCentury | May 5, 2022
Management Tracks
Legault named Egle chairman
Plus Tom Hughes becomes chairman of Totus, and updates from Immunicum, Kbio and more
BioCentury | Apr 6, 2022
Management Tracks
Sabatini out at MIT
Plus Avidity expands role of MacLean and updates from Exscientia, eFFECTOR, Sofinnova and more
BioCentury | Feb 3, 2022
Product Development
Feb. 2 Quick Takes: Pharming plans global submissions for leniolisib
Plus Novo ends Staten deal, new Pfizer vaccine data coming, Novartis scuttles pan-JAK and more
BioCentury | Aug 24, 2021
Deals
Aug. 23 Quick Takes: Pfizer, BioNTech look ahead to pediatric data after FDA approval of Comirnaty
Approval for COVID-19 vaccines from Zydus Cadila, Medigen-Dynavax; plus Sabatini fired, Clover’s U.S. beachhead and more
BioCentury | Sep 13, 2019
Clinical News
Sept. 12 Clinical Quick Takes: Celgene meets in Phase III for AML maintenance therapy; plus Roche, Tocagen, Adverum, Daiichi Sankyo, Apple, Navitor
Items per page:
1 - 10 of 21